Comprehensive glycomics comparison between colon cancer cell cultures and tumours: Implications for biomarker studies

Journal of Proteomics

Volumn 108, Issue , 2014, Pages 146-162

  Chik, Jenny H L ^a   Zhou, Jerry ^b   Moh, Edward S X ^a   Christopherson, Richard ^b   Clarke, Stephen J ^b   Molloy, Mark P ^a   Packer, Nicolle H ^a  

^a MACQUARIE UNIVERSITY   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Biomarkers; Colorectal cancer; Glycosylation; Glycosyltransferases; Mucins

Indexed keywords

ALPHA 2,6 SIALYLTRANSFERASE; CORE 1 SYNTHASE; GLYCAN; MEMBRANE PROTEIN; MUCIN 2; MUCIN 5B; MUCIN 6; SIALYL TN; SIALYLTRANSFERASE; SYNTHETASE; TUMOR MARKER; UNCLASSIFIED DRUG; C1GALT1 PROTEIN, HUMAN; CMP-N-ACETYLNEURAMINATE-ALPHA-N-ACETYLGALACTOSAMINIDE ALPHA-2,6-SIALYLTRANSFERASE; GALACTOSYLTRANSFERASE; MUCIN; TUMOR PROTEIN;

ARTICLE; CANCER TISSUE; COLORECTAL CANCER; COLORECTAL CANCER CELL LINE; CONTROLLED STUDY; EPITHELIUM CELL; HUMAN; HUMAN TISSUE; LIQUID CHROMATOGRAPHY; LS174T CELL LINE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN GLYCOSYLATION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SW1116 CELL LINE; SW480 CELL LINE; SW620 CELL LINE; SW837 CELL LINE; TANDEM MASS SPECTROMETRY; CLINICAL TRIAL; COLON TUMOR; COMPARATIVE STUDY; FEMALE; GENETICS; GLYCOBIOLOGY; INTESTINE MUCOSA; MALE; METABOLISM; PATHOLOGY; TUMOR CELL LINE;

CELL LINE, TUMOR; COLONIC NEOPLASMS; FEMALE; GALACTOSYLTRANSFERASES; GLYCOMICS; HUMANS; INTESTINAL MUCOSA; MALE; MUCINS; NEOPLASM PROTEINS; SIALYLTRANSFERASES; TUMOR MARKERS, BIOLOGICAL;

EID: 84901976686     PISSN: 18743919     EISSN: 18767737     Source Type: Journal    
DOI: 10.1016/j.jprot.2014.05.002     Document Type: Article

References (80)

1. Jemal A., Bray F., Center M.M., Ferlay J., Ward E., Forman D. Global cancer statistics. CA Cancer J Clin 2011, 61(2):69-90.
2. Siegel R., Naishadham D., Jemal A. Cancer statistics. CA Cancer J Clin 2012, 62(1):10-29.
3. Brooks S.A., Carter T.M., Royle L., Harvey D.J., Fry S.A., Kinch C., et al. Altered glycosylation of proteins in cancer: what is the potential for new anti-tumour strategies. Anticancer Agents Med Chem 2008, 8(1):2-21.
4. Kim Y.J., Varki A. Perspectives on the significance of altered glycosylation of glycoproteins in cancer. Glycoconj J 1997, 14(5):569-576.
5. Meany D.L., Chan D.W. Aberrant glycosylation associated with enzymes as cancer biomarkers. Clin Proteomics 2011, 8(1):7.
6. Ono M., Hakomori S. Glycosylation defining cancer cell motility and invasiveness. Glycoconj J 2004, 20(1):71-78.
7. Varki A., Sharon N. Historical background and overview. Essentials of Glycobiology 2009, [Cold Spring Harbor (NY)]. A. Varki (Ed.).
8. Stanley P., Schachter H., Taniguchi N. N-glycans. Essentials of Glycobiology 2009, [Cold Spring Harbor (NY)]. A. Varki (Ed.).
9. Brockhausen I., Schachter H., Stanley P. O-GalNAc glycans. Essentials of Glycobiology 2009, [Cold Spring Harbor (NY)]. A. Varki (Ed.).
10. Brockhausen I. Pathways of O-glycan biosynthesis in cancer cells. Biochim Biophys Acta 1999, 1473(1):67-95.
11. Dahiya R., Itzkowitz S.H., Byrd J.C., Kim Y.S. Mucin oligosaccharide biosynthesis in human colonic cancerous tissues and cell lines. Cancer 1992, 70(6):1467-1476.
12. Balog C.I.A., Stavenhagen K., Fung W.L.J., Koeleman C.A., McDonnell L.A., Verhoeven A., et al. N-glycosylation of colorectal cancer tissues. Mol Cell Proteomics 2012, 11(9):571-585.
13. Kannagi R. Carbohydrate antigen sialyl Lewis A-its pathophysiological significance and induction mechanism in cancer progression. Chang Gung Med J 2007, 30(3):189-209.
14. Magnani J.L., Nilsson B., Brockhaus M., Zopf D., Steplewski Z., Koprowski H., et al. A monoclonal antibody-defined antigen associated with gastrointestinal cancer is a ganglioside containing sialylated lacto-N-fucopentaose II. J Biol Chem 1982, 257(23):14365-14369.
15. Hundt S., Haug U., Brenner H. Blood markers for early detection of colorectal cancer: a systematic review. Cancer Epidemiol Biomarkers Prev 2007, 16(10):1935-1953.
16. Nakamori S., Kameyama M., Imaoka S., Furukawa H., Ishikawa O., Sasaki Y., et al. Involvement of carbohydrate antigen sialyl Lewis X in colorectal cancer metastasis. Dis Colon Rectum 1997, 40(4):420-431.
17. Bresalier R.S., Ho S.B., Schoeppner H.L., Kim Y.S., Sleisenger M.H., Brodt P., et al. Enhanced sialylation of mucin-associated carbohydrate structures in human colon cancer metastasis. Gastroenterology 1996, 110(5):1354-1367.
18. Julien S., Videira P.A., Delannoy P. Sialyl-Tn in cancer: (how) did we miss the target?. Biomol 2012, 2(4):435-466.
19. Brockhausen I. Mucin-type O-glycans in human colon and breast cancer: glycodynamics and functions. EMBO Rep 2006, 7(6):599-604.
20. Robbe-Masselot C., Herrmann A., Maes E., Carlstedt I., Michalski J.C., Capon C. Expression of a core 3 disialyl-Le(x) hexasaccharide in human colorectal cancers: a potential marker of malignant transformation in colon. J Proteome Res 2009, 8(2):702-711.
21. Larsson J.M., Karlsson H., Sjovall H., Hansson G.C. A complex, but uniform O-glycosylation of the human MUC2 mucin from colonic biopsies analyzed by nanoLC/MSn. Glycobiology 2009, 19(7):756-766.
22. Akamine S., Nakagoe T., Sawai T., Tsuji T., Tanaka K., Hidaka S., et al. Differences in prognosis of colorectal cancer patients based on the expression of sialyl Lewisa, sialyl Lewisx and sialyl Tn antigens in serum and tumor tissue. Anticancer Res 2004, 24(4):2541-2546.
23. Itzkowitz S.H., Bloom E.J., Kokal W.A., Modin G., Hakomori S.-I., Kim Y.S. Sialosyl-Tn. A novel mucin antigen associated with prognosis in colorectal cancer patients. Cancer 1990, 66(9):1960-1966.
24. Moriwaki K., Noda K., Furukawa Y., Ohshima K., Uchiyama A., Nakagawa T., et al. Deficiency of GMDS leads to escape from NK cell-mediated tumor surveillance through modulation of TRAIL signaling. Gastroenterology 2009, 137(1):188-198.
25. Morgenthaler J., Kemmner W., Brossmer R. Sialic acid dependent cell adhesion to collagen IV correlates with in vivo tumorigenicity of the human colon carcinoma sublines HCT116, HCT116a and HCT116b. Biochem Biophys Res Commun 1990, 171(2):860-866.
26. Vercoutter-Edouart A.-S., Slomianny M.-C., Dekeyzer-Beseme O., Haeuw J.-F., Michalski J.-C. Glycoproteomics and glycomics investigation of membrane N-glycosylproteins from human colon carcinoma cells. Proteomics 2008, 8(16):3236-3256.
27. Terada M., Khoo K.H., Inoue R., Chen C.I., Yamada K., Sakaguchi H., et al. Characterization of oligosaccharide ligands expressed on SW1116 cells recognized by mannan-binding protein. A highly fucosylated polylactosamine type N-glycan. J Biol Chem 2005, 280(12):10897-10913.
28. Moyret C., Madsen M.W., Cooke J., Briand P., Theillet C. Gradual selection of a cellular clone presenting a mutation at codon 179 of the p53 gene during establishment of the immortalized human breast epithelial cell line HMT-3522. Exp Cell Res 1994, 215(2):380-385.
29. Hughes P., Marshall D., Reid Y., Parkes H., Gelber C. The costs of using unauthenticated, over-passaged cell lines: how much more data do we need?. Biotechniques 2007, 43(5):575. [577-8, 581-2 passim].
30. Zhou J., Belov L., Huang P.Y., Shin J.-S., Solomon M.J., Chapuis P.H., et al. Surface antigen profiling of colorectal cancer using antibody microarrays with fluorescence multiplexing. J Immunol Methods 2010, 355(1-2):40-51.
31. Davis N.C., Newland R.C. Terminology and classification of colorectal adenocarcinoma: the Australian clinico-pathological staging system. Aust N Z J Surg 1983, 53(3):211-221.
32. Fielding L.P., Arsenault P.A., Chapuis P.H., Dent O., Gathright B., Hardcastle J.D., et al. Clinicopathological staging for colorectal cancer: an International Documentation System (IDS) and an International Comprehensive Anatomical Terminology (ICAT). J Gastroenterol Hepatol 1991, 6(4):325-344.
33. Lee A., Kolarich D., Haynes P.A., Jensen P.H., Baker M.S., Packer N.H. Rat liver membrane glycoproteome: enrichment by phase partitioning and glycoprotein capture. J Proteome Res 2009, 8(2):770-781.
34. Chick J.M., Haynes P.A., Molloy M.P., Bjellqvist B., Baker M.S., Len A.C. Characterization of the rat liver membrane proteome using peptide immobilized pH gradient isoelectric focusing. J Proteome Res 2008, 7(3):1036-1045.
35. Kilcoyne M., Gerlach J.Q., Gough R., Gallagher M.E., Kane M., Carrington S.D., et al. Construction of a natural mucin microarray and interrogation for biologically relevant glyco-epitopes. Anal Chem 2012, 84(7):3330-3338.
36. Jensen P.H., Karlsson N.G., Kolarich D., Packer N.H. Structural analysis of N- and O-glycans released from glycoproteins. Nat Protoc 2012, 7(7):1299-1310.
37. Everest-Dass A., Abrahams J., Kolarich D., Packer N., Campbell M. Structural feature ions for distinguishing N- and O-linked glycan isomers by LC-ESI-IT MS/MS. J Am Soc Mass Spectrom 2013, 24(6):895-906.
38. Harvey D.J., Royle L., Radcliffe C.M., Rudd P.M., Dwek R.A. Structural and quantitative analysis of N-linked glycans by matrix-assisted laser desorption ionization and negative ion nanospray mass spectrometry. Anal Biochem 2008, 376(1):44-60.
39. Hayes C.A., Karlsson N.G., Struwe W.B., Lisacek F., Rudd P.M., Packer N.H., et al. UniCarb-DB: a database resource for glycomic discovery. Bioinformatics 2011, 27(9):1343-1344.
40. Harvey D.J. Fragmentation of negative ions from carbohydrates: part 3. Fragmentation of hybrid and complex N-linked glycans. J Am Soc Mass Spectrom 2005, 16(5):647-659.
41. Lin P., Hu S.W., Chang T.H. Correlation between gene expression of aryl hydrocarbon receptor (AhR), hydrocarbon receptor nuclear translocator (Arnt), cytochromes P4501A1 (CYP1A1) and 1B1 (CYP1B1), and inducibility of CYP1A1 and CYP1B1 in human lymphocytes. Toxicol Sci 2003, 71(1):20-26.
42. Schmittgen T.D., Livak K.J. Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc 2008, 3(6):1101-1108.
43. Momburg F., Moldenhauer G., Hammerling G.J., Moller P. Immunohistochemical study of the expression of a Mr 34,000 human epithelium-specific surface glycoprotein in normal and malignant tissues. Cancer Res 1987, 47(11):2883-2891.
44. Moll R., Franke W.W., Schiller D.L., Geiger B., Krepler R. The catalog of human cytokeratins: patterns of expression in normal epithelia, tumors and cultured cells. Cell 1982, 31(1):11-24.
45. Franke W.W., Schmid E., Osborn M., Weber K. Different intermediate-sized filaments distinguished by immunofluorescence microscopy. Proc Natl Acad Sci 1978, 75(10):5034-5038.
46. Holmen Larsson J.M., Thomsson K.A., Rodriguez-Pineiro A.M., Karlsson H., Hansson G.C. Studies of mucus in mouse stomach, small intestine, and colon. III. Gastrointestinal Muc5ac and Muc2 mucin O-glycan patterns reveal a regiospecific distribution. Am J Physiol Gastrointest Liver Physiol 2013, 305(5):G357-G363.
47. Everest-Dass A.V., Jin D., Thaysen-Andersen M., Nevalainen H., Kolarich D., Packer N.H. Comparative structural analysis of the glycosylation of salivary and buccal cell proteins: innate protection against infection by Candida albicans. Glycobiology 2012, 22(11):1465-1479.
48. Robbe C., Capon C., Coddeville B., Michalski J.C. Structural diversity and specific distribution of O-glycans in normal human mucins along the intestinal tract. Biochem J 2004, 384(Pt 2):307-316.
49. Ogata S., Chen A., Itzkowitz S.H. Use of model cell lines to study the biosynthesis and biological role of cancer-associated sialosyl-Tn antigen. Cancer Res 1994, 54(15):4036-4044.
50. Axelsson M.A.B., Karlsson N.G., Steel D.M., Ouwendijk J., Nilsson T., Hansson G.C. Neutralization of pH in the Golgi apparatus causes redistribution of glycosyltransferases and changes in the O-glycosylation of mucins. Glycobiology 2001, 11(8):633-644.
51. Priatel J.J., Sarkar M., Schachter H., Marth J.D. Isolation, characterization and inactivation of the mouse Mgat3 gene: the bisecting N-acetylglucosamine in asparagine-linked oligosaccharides appears dispensable for viability and reproduction. Glycobiology 1997, 7(1):45-56.
52. Pinto R., Carvalho A.S., Conze T., Magalhaes A., Picco G., Burchell J.M., et al. Identification of new cancer biomarkers based on aberrant mucin glycoforms by in situ proximity ligation. J Cell Mol Med 2012, 16(7):1474-1484.
53. Sasaki M., Yamato T., Nakanuma Y. Expression of sialyl-Tn, Tn and T antigens in primary liver cancer. Pathol Int 1999, 49(4):325-331.
54. Rodriguez-Pineiro A.M., Post S., Johansson M.E., Thomsson K.A., Nesvizhskii A.I., Hansson G.C. Proteomic study of the mucin granulae in an intestinal goblet cell model. J Proteome Res 2012, 11(3):1879-1890.
55. Becker S., Oelschlaeger T.A., Wullaert A., Pasparakis M., Wehkamp J., Stange E.F., et al. Bacteria regulate intestinal epithelial cell differentiation factors both in vitro and in vivo. PLoS One 2013, 8(2):e55620.
56. Bu X.D., Li N., Tian X.Q., Huang P.L. Caco-2 and LS174T cell lines provide different models for studying mucin expression in colon cancer. Tissue Cell 2011, 43(3):201-206.
57. van Klinken B.J., Oussoren E., Weenink J.J., Strous G.J., Buller H.A., Dekker J., et al. The human intestinal cell lines Caco-2 and LS174T as models to study cell-type specific mucin expression. Glycoconj J 1996, 13(5):757-768.
58. Jankova L., Chan C., Fung C.L., Song X., Kwun S.Y., Cowley M.J., et al. Proteomic comparison of colorectal tumours and non-neoplastic mucosa from paired patient samples using iTRAQ mass spectrometry. Mol Biosyst 2011, 7(11):2997-3005.
59. Itzkowitz S.H., Yuan M., Montgomery C.K., Kjeldsen T., Takahashi H.K., Bigbee W.L., et al. Expression of Tn, sialosyl-Tn, and T antigens in human colon cancer. Cancer Res 1989, 49(1):197-204.
60. Imada T., Rino Y., Hatori S., Takahashi M., Amano T., Kondo J., et al. Sialyl Tn antigen expression is associated with the prognosis of patients with advanced colorectal cancer. Hepatogastroenterology 1999, 46(25):208-214.
61. Ogata S., Koganty R., Reddish M., Michael Longenecker B., Chen A., Perez C., Itzkowitz S. Different modes of sialyl-Tn expression during malignant transformation of human colonic mucosa. Glycoconj J 1998, 15(1):29-35.
62. Thor A., Ohuchi N., Szpak C.A., Johnston W.W., Schlom J. Distribution of oncofetal antigen tumor-associated glycoprotein-72 defined by monoclonal antibody B72.3. Cancer Res 1986, 46(6):3118-3124.
63. Harduin-Lepers A., Vallejo-Ruiz V., Krzewinski-Recchi M.A., Samyn-Petit B., Julien S., Delannoy P. The human sialyltransferase family. Biochimie 2001, 83(8):727-737.
64. Marcos N.T., Pinho S., Grandela C., Cruz A., Samyn-Petit B., Harduin-Lepers A., et al. Role of the human ST6GalNAc-I and ST6GalNAc-II in the synthesis of the cancer-associated Sialyl-Tn antigen. Cancer Res 2004, 64(19):7050-7057.
65. Sewell R., Bäckström M., Dalziel M., Gschmeissner S., Karlsson H., Noll T., et al. The ST6GalNAc-I sialyltransferase localizes throughout the Golgi and is responsible for the synthesis of the tumor-associated Sialyl-Tn O-glycan in human breast cancer. J Biol Chem 2006, 281(6):3586-3594.
66. Brockhausen I., Yang J., Dickinson N., Ogata S., Itzkowitz S.H. Enzymatic basis for sialyl-Tn expression in human colon cancer cells. Glycoconj J 1998, 15(6):595-603.
67. Glanemann C., Loos A., Gorret N., Willis L.B., O'Brien X.M., Lessard P.A., et al. Disparity between changes in mRNA abundance and enzyme activity in Corynebacterium glutamicum: implications for DNA microarray analysis. Appl Microbiol Biotechnol 2003, 61(1):61-68.
68. Ju T., Cummings R.D. Protein glycosylation: chaperone mutation in Tn syndrome. Nature 2005, 437(7063):1252.
69. Huang J., Che M.-I., Lin N.-Y., Hung J.-S., Huang Y.-T., Lin W.-C., et al. The molecular chaperone Cosmc enhances malignant behaviors of colon cancer cells via activation of Akt and ERK. Mol Carcinog 2014, 53(Suppl 1):E62-E71.
70. Iwai T., Inaba N., Naundorf A., Zhang Y., Gotoh M., Iwasaki H., et al. Molecular cloning and characterization of a novel UDP-GlcNAc:GalNAc-peptide β1,3-N-acetylglucosaminyltransferase (β3Gn-T6), an enzyme synthesizing the core 3 structure of O-glycans. J Biol Chem 2002, 277(15):12802-12809.
71. Vavasseur F., Yang J.M., Dole K., Paulsen H., Brockhausen I. Synthesis of O-glycan core 3: characterization of UDP-GlcNAc: GalNAc-R beta 3-N-acetyl-glucosaminyltransferase activity from colonic mucosal tissues and lack of the activity in human cancer cell lines. Glycobiology 1995, 5(3):351-357.
72. Barrow H., Tam B., Duckworth C.A., Rhodes J.M., Yu L.G. Suppression of core 1 Gal-transferase is associated with reduction of TF and reciprocal increase of Tn, sialyl-Tn and Core 3 glycans in human colon cancer cells. PLoS One 2013, 8(3):e59792.
73. Iwai T., Kudo T., Kawamoto R., Kubota T., Togayachi A., Hiruma T., et al. Core 3 synthase is down-regulated in colon carcinoma and profoundly suppresses the metastatic potential of carcinoma cells. Proc Natl Acad Sci U S A 2005, 102(12):4572-4577.
74. Conze T., Carvalho A.S., Landegren U., Almeida R., Reis C.A., David L., et al. MUC2 mucin is a major carrier of the cancer-associated sialyl-Tn antigen in intestinal metaplasia and gastric carcinomas. Glycobiology 2010, 20(2):199-206.
75. Thomsson K.A., Prakobphol A., Leffler H., Reddy M.S., Levine M.J., Fisher S.J., et al. The salivary mucin MG1 (MUC5B) carries a repertoire of unique oligosaccharides that is large and diverse. Glycobiology 2002, 12(1):1-14.
76. Williams S.J., Wreschner D.H., Tran M., Eyre H.J., Sutherland G.R., McGuckin M.A. Muc13, a novel human cell surface mucin expressed by epithelial and hemopoietic cells. J Biol Chem 2001, 276(21):18327-18336.
77. Olzmann J.A., Kopito R.R., Christianson J.C. The mammalian endoplasmic reticulum-associated degradation system. Cold Spring Harb Perspect Biol 2013, 5(9).
78. Haynes C.M., Titus E.A., Cooper A.A. Degradation of misfolded proteins prevents ER-derived oxidative stress and cell death. Mol Cell 2004, 15(5):767-776.
79. Geisberg, Joseph V., Z. Moqtaderi, X. Fan, F. Ozsolak, and K. Struhl, Global analysis of mRNA isoform half-lives reveals stabilizing and destabilizing elements in yeast. Cell. 156(4): p. 812-824.
80. Flatmark K., Maelandsmo G.M., Martinsen M., Rasmussen H., Fodstad O. Twelve colorectal cancer cell lines exhibit highly variable growth and metastatic capacities in an orthotopic model in nude mice. Eur J Cancer 2004, 40(10):1593-1598.